Why the study?
Single anastomosis sleeve ileal (SASI) bypass has emerged as a potential solution for sleeve gastrectomy failure, but mid-term outcomes on weight loss, metabolic improvement, and postoperative complications required investigation.
Does single anastomosis sleeve ileal (SASI) bypass improve weight loss and comorbidities in patients with failed sleeve gastrectomy?
Does single anastomosis sleeve ileal (SASI) bypass improve weight loss and comorbidities in patients with failed sleeve gastrectomy?
SASI conversion after failed sleeve gastrectomy provides significant mid-term weight loss and metabolic improvements, though de novo GERD remains a concern.
Answers are grounded in this paper and cite their sources.
May support SASI conversion after failed sleeve; leaves open need for RCTs on durability and GERD.
BACKGROUND: The single anastomosis sleeve ileal (SASI) bypass, a hybrid bariatric procedure combining sleeve gastrectomy (SG) and ileal bypass, has emerged as a potential solution for SG failure, offering both restrictive and malabsorptive effects. This study investigates the mid-term outcomes of SASI in patients undergoing conversion due to SG failure, with a focus on weight loss, metabolic improvement, and postoperative complications. METHODS: This retrospective study included 44 consecutive patients who underwent SASI after SG failure at a tertiary bariatric referral center between May 2019 and June 2024. Patients were assessed for demographic, anthropometric, and comorbidity data, with follow-up at 6, 12, 18, and 24 months. Primary outcomes included weight loss and improvement in comorbidities, while secondary outcomes focused on surgical complications and procedure-related issues. RESULTS: The mean BMI decreased from 39.1 ± 7.2 kg/m 2 at the time of SASI to 30.5 ± 5.9 kg/m 2 and 27.5 ± 4.8 kg/m 2 at 12 and 24 months, respectively, with a %TWL of 21.5 ± 7.8% at 12 months and 29.7 ± 9.5% at 24 months. Significant improvements were observed in obesity-related comorbidities, including remission of type 2 diabetes, sleep apnea, and hypertension. Short-term complications occurred in 11.3% of patients, with no postoperative mortality. Mid-term follow-up revealed that 65% of patients experienced resolution of gastroesophageal reflux disease (GERD), although 11.3% developed de novo GERD symptoms. CONCLUSION: SASI conversion after SG failure is associated with significant weight loss and favorable metabolic outcomes. However, GERD remains a challenge, and careful patient selection and surgical technique are crucial. Larger, multi-center studies with longer follow-up are needed to further refine the role of SASI in revisional bariatric surgery.
No takes yet. Share an insight, caveat, or question.
Carandina et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: